Home

Paul Campanelli

CIK 1392459 · President, CEO · last filed 2022-10-12

Paul Campanelli is a President, CEO who has filed 64 SEC Form 4 insider transactions across 3 companies since 2007. Across all open-market trades the lifetime net is −$6.0M, making them a net seller over the disclosed history. 31 SEC filings were submitted jointly with Endo International plc.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$0

Companies

3

Total Filings

64

Lifetime Open-Market Net

-$6.01M

Filer Profile

Reported Address
C/O PAR PHARMACEUTICAL COMPANIES, INC.
ONE RAM RIDGE ROAD
CHESTNUT RIDGE, NY 10977
Related Filers
Endo International plc — 31 joint filings, latest 2021-04-06
Profile details as reported on the filer's SEC submissions — for individual insiders the address is often in care of the issuer. Related filers are identified from jointly filed SEC submissions and shared reported addresses. View filings on SEC EDGAR.

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
Convey Health Solutions Holdings, Inc. (CNVY) Delisted Director — $10.51 — $0 1 2022-03-30
Endo International plc (ENDP) Delisted Director 1,795,934 $0.29 $525.5K $393.6K 30 2021-04-06
PAR PHARMACEUTICAL COMPANIES, INC. (PRX) Delisted Chief Operating Officer 46,106 — — -$6.40M 31 2012-01-13

Recent Filings

64 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2022-10-12 — Disp (D) — $0
2022-03-30 Convey Health Solutions Holdings, Inc. (CNVY) Delisted Grant (A) — $0 EDGAR
2021-04-06 Endo International plc (ENDP) Delisted Mixed −266,484 -$2.47M EDGAR
2021-03-31 Endo International plc (ENDP) Delisted Tax (F) −72,926 -$533.3K EDGAR
2020-08-12 Endo International plc (ENDP) Delisted Tax (F) −116,789 -$397.1K EDGAR
2020-04-06 Endo International plc (ENDP) Delisted Tax (F) −146,400 -$462.6K EDGAR
2020-03-31 Endo International plc (ENDP) Delisted Tax (F) −72,926 -$256.7K EDGAR
2020-02-25 Endo International plc (ENDP) Delisted Mixed −137,173 -$731.4K EDGAR
2019-10-01 Endo International plc (ENDP) Delisted Tax (F) −1,874 -$5.8K EDGAR
2019-08-13 Endo International plc (ENDP) Delisted Tax (F) −116,790 -$290.8K EDGAR
Showing 1–10 of 64
Page 1 of 7
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.